Evidence map›Paper›PMID 32398955›Full record

ArticleInternational journal of biological sciences2020

Yanbo Zhu, Zi Yan, Zhonghua Du, Shilin Zhang, Changhao Fu, Ying Meng, Xue Wen, Yizhuo Wang, Andrew R Hoffman, Ji-Fan Hu and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of biological sciences · 2023
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yanbo ZhuKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Zi YanDivision of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Zhonghua DuKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Shilin ZhangKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Changhao FuStanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Ying MengKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Xue WenKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Yizhuo WangKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Andrew R HoffmanStanford University Medical School, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Ji-Fan HuKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Jiuwei CuiKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Wei LiKey Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Stem Cell and Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Jilin University · CNFirst Hospital of Jilin University · CNStanford University · USVA Palo Alto Health Care System · US

Funding

The Role of Long Noncoding RNAs in CancerI01BX002905 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI HOFFMAN, ANDREW R · 2016 to 2023
–
BLRD VA I01 BX002905
6 · The paper itself

Abstract

Induced pluripotent stem cells (iPSCs), derived from reprogramming of somatic cells by a cocktail of transcription factors, have the capacity for unlimited self-renewal and the ability to differentiate into all of cell types present in the body. iPSCs may have therapeutic potential in regenerative medicine, replacing injured tissues or even whole organs. In this study, we examine epigenetic factors embedded in the specific 3-dimensional intrachromosomal architecture required for the activation of endogenous pluripotency genes. Using chromatin RNA

Indexed as

Cellular ReprogrammingAnimalsBiomarkersChromatinEmbryoid BodiesEpigenesis, GeneticFibroblastsGene Knockdown TechniquesInduced Pluripotent Stem CellsMiceOctamer Transcription Factor-3Promoter Regions, GeneticRNA, Long NoncodingRNA-SeqSOXB1 Transcription FactorsTranscriptomeBiomarkersChromatinOctamer Transcription Factor-3Pou5f1 protein, mouseRNA, Long NoncodingSox2 protein, mouseSOXB1 Transcription Factorsepigeneticsintrachromosomal interactionlncRNApluripotencystem cell

Identifiers

PMID32398955
PMCPMC7211171
OpenAlexW3015578067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.